Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - ACCOUNTS PAYABLE
Accounts Payable RARE - Ultragenyx Pharmaceutical Inc.
38.8 M
LAST VALUE
-5.36%
2 YEAR CAGR
24.67%
5 YEAR CAGR
23.08%
10 YEAR CAGR